採用
Bio-Rad

Bio-Rad
Global leader in life science research and clinical diagnostics
Life Sciences
Laboratory Automation
Bioanalytical Testing
Quality Control
Research & Development
募集中のポジション
0件のポジション
現在募集中のポジションはありません
製品・サービス
MU
multi-well plate
Laboratory Consumables

Antibodies
Life Science Reagents

Kits
Life Science Reagents

Primary antibodies
Antibodies

Secondary antibodies
Antibodies

Fluorescent western blotting antibodies
Antibodies

HRP conjugates
Antibodies

Matched antibody pairs
Antibodies

Negative isotype controls
Antibodies

Star bright dyes
Fluorescent Reagents

AP conjugates
Antibodies

multi-well plate
Laboratory Consumables
経営陣
AS
Alice Schwartz
Founder
AS
Alice Schwartz
Founder
DS
David Schwartz
Co-Founder
類似企業

Insitro
Series C
Biotechnology company.
South San Francisco, CA
201-500
Valuation $2.4B
10 open jobs

Illumina
Public
Unlocking the power of the genome.
San Diego, California
5,001-10,000
Valuation $36.0B
175 open jobs

CRISPR Therapeutics
Public
Leading company in the technology industry
Cambridge, Massachusetts, United States
201-500
Valuation $2.9B
6 open jobs

Eli Lilly
Public
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries
10,001+
Valuation $588B
727 open jobs

Atomwise
Series B
AI-powered drug discovery company
San Francisco, CA
51-200
Valuation $3B

Regeneron
Public
Focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations int...
Westchester County, New York
10,001+
Valuation $76B
422 open jobs
ニュース&話題
All
X
News
HN
YouTube
Citigroup downgrades Bio-Rad Laboratories (BIO.B) - MSN
MSN
News
·
3日前
Bio-Rad Laboratories (NYSE:BIO.B) Share Price Passes Below 200-Day Moving Average - Time to Sell? - MarketBeat
MarketBeat
News
·
3日前
Bio-Rad Laboratories, Inc. (NYSE:BIO) Short Interest Update - MarketBeat
MarketBeat
News
·
3日前
Adapt: an LLM-based memory layer that restructures itself
HN
·
4日前
·
1
Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026
·
4日前
·
1
もっと見る (残り15件)
総閲覧数
0
応募クリック数
0
模擬応募者数
0
スクラップ
0
レビュー
3.2
2件のレビュー
ワークライフバランス
3.0
報酬
3.0
企業文化
2.5
キャリア
2.5
経営陣
2.0
25%
友人に勧める
良い点
Quality control systems in place
Gel activation works properly
Good protein separation performance
改善点
Lack of clear guidance from management
Poor decision-making process transparency
Product compatibility issues
給与レンジ
9件のデータ
Mid/L4
Mid/L4
2件のレポート
$125,870
年収総額
基本給
$117,291
ストック
-
$125,870
$125,870
面接体験
46件の面接
難易度
3.4
/ 5
期間
2-5w
内定率
34%
体験
ポジティブ 69%
普通 21%
ネガティブ 10%
面接プロセス
1
Phone Screen
2
Technical Interview
3
Hiring Manager
4
Team Fit
連絡先・所在地